Jan 10, 2023 / 11:45PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst
Good afternoon, everyone. I'm Robbie Marcus, the medtech analyst at JPMorgan. Very happy to introduce our next session with Zimmer Biomet. I'm going to bring up Bryan Hanson, CEO, and then we'll do a little Q&A after. Bryan?
Bryan C. Hanson - Zimmer Biomet Holdings, Inc. - Chairman, President & CEO
Thanks, Robbie. All right. Hi. Can you guys hear me okay? All right, great. No applause, please. All right. So I'm obviously the Bryan Hanson, CEO of Zimmer Biomet, and I'm going to spend hopefully about 20 minutes going over some content that I think will be helpful for the discussion that we have after for the Q&A. This is the sexiest slide that I have in the deck. There's a lot of words on this. I'm not going to go through those words, thank goodness. But I think you guys know the story around forward-looking statements. So I'll give you a minute to peruse this just so legal knows you looked at it. That was the pause.
Okay. So here's -- I'm going to spend just a little
Zimmer Biomet Holdings Inc at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot